Pre-existing insulin autoantibodies predict efficacy of otelixizumab in preserving residual beta cell function in recent-onset type 1 diabetes

Simke Demeester, Bart Keymeulen, Leonard Kaufman, Annelien Van Dalem, Eric Balti Vounsia, Ursule Van De Velde, Patrick Goubert, Katrijn Verhaeghen, Howard Davidson, J. Wenzlau, Ilse Weets, Daniel Pipeleers, Frans Gorus

Research output: Contribution to journal › Article › peer-review

23 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Pre-existing insulin autoantibodies predict efficacy of otelixizumab in preserving residual beta cell function in recent-onset type 1 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences